Inventor · Huddinge, SE

Bertil Samuelsson

18Patents

5h-index

31Co-inventors

66Inventor score

Filing activity: Jun 15, 2000 → Apr 25, 2022

Most-cited inventions

Patent	Title	Area	Cited by	Status
US7608590B2	HCV NS-3 serine protease inhibitors	Chemistry; Metallurgy	21	Expired
US7700552B2	Macrocyclic inhibitors of hepatitis C virus	Chemistry; Metallurgy	18	Active
US7671032B2	HCV NS-3 serine protease inhibitors	Chemistry; Metallurgy	12	Expired
US8242119B2	Protease inhibitors	Emerging Cross-Sectional Technologies	6	Active
US8735395B2	Protease inhibitors	Emerging Cross-Sectional Technologies	5	Active
US9200006B2	Protease inhibitors	Emerging Cross-Sectional Technologies	5	Active
US8426421B2	Protease inhibitors	Emerging Cross-Sectional Technologies	5	Active
US8937080B2	Pyrimidine substituted macrocyclic HCV inhibitors	Emerging Cross-Sectional Technologies	3	Active
US7807677B2	HIV protease inhibitors	Chemistry; Metallurgy	2	Active
US6887881B1	Bispidine compounds useful in the treatment of cardiac arrythmias	Human Necessities	2	Expired
US10723709B2	Protease inhibitors	Emerging Cross-Sectional Technologies	1	Active
US8338471B2	(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors	Chemistry; Metallurgy	1	Active
US10172846B2	HCV NS-3 serine protease inhibitors	Chemistry; Metallurgy	0	Active
US11312693B2	Protease inhibitors	Emerging Cross-Sectional Technologies	0	Active
US8022092B2	(2,5-dioxoimidazolidin-1-yl)-N-hydroxy-acetamides as metalloproteinase inhibitors	Chemistry; Metallurgy	0	Active
US10329266B2	Protease inhibitors	Emerging Cross-Sectional Technologies	0	Active
US9428517B2	Protease inhibitors	Emerging Cross-Sectional Technologies	0	Active
US12378209B2	Protease inhibitors	Emerging Cross-Sectional Technologies	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.